alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 3.3

                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                                       OF
                               HAGLER BAILLY, INC.

     Hagler  Bailly,  Inc.  (the  "Corporation"),  a  corporation  organized and
existing  under  and by virtue of the  General  Corporation  Law of the State of
Delaware, does hereby certify:

     FIRST:  That a  meeting  of the  Board  of  Directors  of the  Corporation,
resolutions  were  duly  adopted  setting  forth  a  proposed  amendment  of the
Certificate of Incorporation of the Corporation,  declaring such amendment to be
advisable and calling for such resolutions to be considered at a special meeting
of the  shareholders  of the  Corporation.  The  resolution  setting  forth  the
proposed amendment is as follows:

          RESOLVED  FURTHER,  that the Board of Directors of the Company  hereby
     approves and adopt the following amendment (the "Certificate Amendment") to
     the  relevant  part of  Article 4 of the  Company's  Amended  and  Restated
     Certificate of Incorporation;

     "4. Capital Stock. The total number of shares of all classes of the capital
     stock which the Corporation shall have authority to issue is:

     50,000,000 shares, par value one cent ($0.01) per share of Common Stock"

     SECOND: That thereafter,  pursuant to resolution of its Board of Directors,
the special meeting of shareholders of the Corporation was duly called and held,
upon notice in accordance with Section 222 of the General Corporation Law of the
State of  Delaware,  at which the  necessary  number of  shares as  required  by
statute was voted in favor of the amendment.

     THIRD:  That  the  amendment  was  duly  adopted  in  accordance  with  the
provisions  of  Section  242 of the  General  Corporation  Law of the  State  of
Delaware.




     IN  WITNESS  WHEREOF,  the  Corporation  has  caused  this  Certificate  of
Amendment  to be signed by  Henri-Claude  A.  Bailly,  its  President  and Chief
Executive Officer,  and attested by Stephen V.R. Whitman, its Vice President and
General Counsel, this 11th day of September 1998.

                                 HAGLER BAILLY

                                 By: /s/ Henri-Claude Bailly
                                         Henri-Claude A. Bailly
                                         President and Chief
                                         Executive Officer


                                 ATTEST:  /s/ Stephen V.R. Whitman
                                              Stephen V.R. Whitman
                                              Vice President and
                                              General Counsel
Exhibit 10.1
 BIOCLINICA, INC.
2002 STOCK INCENTIVE PLAN
 AS AMENDED AND RESTATED EFFECTIVE MAY 11, 2005
 AND AS SUBSEQUENTLY AMENDED AND RESTATED MAY 14, 2008 AND  JANUARY 20, 2010
 ARTICLE ONE
 GENERAL PROVISIONS
 I. PURPOSE OF THE PLAN
      II. STRUCTURE OF THE PLAN




---



##### 



III. ADMINISTRATION OF THE PLAN
     IV. ELIGIBILITY
   2




---



##### 



provided,
however,
 V. STOCK SUBJECT TO THE PLAN
   3




---



##### 



4




---



##### 



provided,
however
  5




---



##### 



ARTICLE TWO
 DISCRETIONARY GRANT PROGRAM
 I. OPTION TERMS
 provided, however
 Exercise Price
       6




---



##### 



Exercise and Term of Options .
 Effect of Termination of Service
       7




---



##### 



Stockholder Rights .
 Repurchase Rights . lower
 8




---



##### 



Transferability of Options
 Incentive Options
 Non-Statutory Options
 Beneficiary Designations
 II. INCENTIVE OPTIONS
 not
 Eligibility .
 Dollar Limitation .
 9




---



##### 



10% Stockholder .
 III. CHANGE IN CONTROL
 not
   10




---



##### 



provided
    11




---



##### 



IV. PROHIBITION ON REPRICING PROGRAMS
  V. STOCK ISSUANCE TERMS
   12




---



##### 



13




---



##### 



ARTICLE THREE
 MISCELLANEOUS
 I. TAX WITHHOLDING
   Stock Withholding
 Stock Delivery
 II. SHARE ESCROW/LEGENDS
  III. EFFECTIVE DATE AND TERM OF THE PLAN
  14




---



##### 



earliest
 IV. AMENDMENT OF THE PLAN
   V. USE OF PROCEEDS
  15




---



##### 



VI. REGULATORY APPROVALS
   VII. NO EMPLOYMENT/SERVICE RIGHTS
  16




---



##### 



APPENDIX
  Board
 Change in Control
 unless
   Code
 Common Stock
 Compensation Committee
 A-1.




---



##### 



Corporation
 Discretionary Grant Program
 Employee
 Exercise Date
 Fair Market Value
   Family Member
 Incentive Option
 A-2.




---



##### 



Involuntary Termination
   Misconduct
 1934 Act
 Non-Statutory Option
 Optionee
 Parent
 Permanent Disability or Permanently Disabled
 A-3.




---



##### 



Plan
 Plan Administrator
 2010 Restatement
 2010 Restatement Effective Date
 Secondary Board Committee
 Section 16 Insider
 Service however
 Stock Exchange
 A-4.




---



##### 



Subsidiary
 10% Stockholder
 Withholding Taxes
 A-5.
NoFire Technologies, Inc. (NFTI)
Code of Ethics for the CEO and CFO

The Chief Executive Officer ("CEO"), or those performing similar
functions, and all Senior Financial Officers (including
particularly the Chief Financial
Officer) are subject to the following specific policies relating
to ethical conduct and fair dealing, conflicts of interest,
confidentiality of NFTI information and compliance with law

Be committed to the highest standards of honest and ethical
conduct, including the ethical handling of actual or apparent
conflicts of interest between their personal and professional
relationships in the performance of their duties as CEO and
Senior Financial Officers of NFTI.

Be committed to the full, fair, accurate, timely and
understandable disclosure in reports and documents that NFTI file
with, or submits to, the SEC and in other public communications
made by NFTI, of all information relating to NFTI, its financial
condition and results of operations.

Be committed to compliance with all applicable governmental laws,
rules and regulations relating to the conduct of the businesses
of NFTI and to required reports regarding the financial condition
and results of business operations of NFTI, including the laws of
all countries in which NFTI operates.

Act in good faith, responsibly, with due care, competence and
diligence, without misrepresenting material facts or allowing
one' s independent judgment to be subordinated to any personal
interest.

Respect the confidentiality of information acquired in the course
of serving as CEO or a Senior Financial Officer of NFTI except
when authorized or otherwise legally obligated to make
disclosure. Confidential information shall not be used for
personal advantage.

Report violations of this Code of Ethics to The General Counsel
or directly to the Audit Committee of the Board of Directors of
NFTI, as soon as practicable after learning of any such
violation.

   Report to the General Counsel or Audit Committee any
   information concerning
significant deficiencies in the design or operation of
internal controls which could adversely affect  NFTI's ability
to record, process, summarize and report financial data or (b)
any fraud, whether or not material, that involves management:
or other employees who have a
  significant role in NFTI's financial reporting, disclosure or
internal  controls.

Report to the General Counsel or Audit Committee any material
violations of the securities or other laws, rules or regulations
applicable to NFTI and the operations of its business, by NFTI or
any agent thereof.
Hold themselves accountable for adherence to this Code of Ethics,
and Understand that NFTI's  Board of Directors will hold them
accountable, as CEO or Senior Financial Officers of NFTI, to this
Code of Ethics.

Exhibit 1
<PAGE>


                                                                    EXHIBIT 32.1



                                WRITTEN STATEMENT
  OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL OFFICER
                           PURSUANT TO 18 U.S.C. 13350


Solely for the purpose of complying with 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned President and
Chief Executive Officer and the Chief Financial Officer of Noble International
Ltd. (the "Company"), hereby certify that to the best of our knowledge the
Quarterly Report of the Company on Form 10-Q for the quarter ended June 30, 2004
fully complies with the requirements of Section 13(a) of the Securities Exchange
Act of 1934 and that information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Date: August 13, 2004         By: /s/ Christopher L. Morin
                                 ------------------------------------------
                              Name: Christopher L. Morin
                              Title:President and Chief Executive Officer
                              (Principal Executive Officer) of
                              Noble International, Ltd.




Date: August 13, 2004         By: /s/  Jay J. Hansen
                                 -------------------------------------------
                              Name: Jay J. Hansen
                              Title: Chief Financial Officer
                              (Principal Financial Officer) of
                              Noble International, Ltd.
EXHIBIT 99.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with this quarterly report on Form 10-Q of Versata, Inc. (the Company) for the period ended January 31, 2003, as filed with the
Securities and Exchange Commission on March 14, 2003 (the Report), I, Eugene Wong, Chief Executive Officer and Director of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company as of the date and for the periods expressed in the Report.



|                     |  | 
|-------------------- |  | 
|Date: March 14, 2003 |  | 
|                     |  | 
|                     |  | 
|                     |  |
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Bay Banks of Virginia, Inc. (the Company) on Form 10-Q for the period ending September 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the
Report), the undersigned Chief Executive Officer and Principal Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002 that based on his
knowledge and belief: 1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and 2) the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company as of and for the periods covered in the Report.



|                                               
|-----------------------------------------------
|/s/ Austin L. Roberts, III                     
|Austin L. Roberts, III, Chief Executive Officer
|                                               
|/s/ Deborah M. Evans                           
|Deborah M. Evans, Treasurer                    

November 6, 2006

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 will be retained by Bay Banks of Virginia, Inc., and furnished
to the Securities and Exchange Commission and its staff upon request.



23
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Grain Legume Genetics Physiology Research: Pullman, WA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Pullman, Washington Grain Legume Genetics Physiology Research People & Locations







Sheri L McGrew
                        Grain Legume Genetics Physiology Research

                        




                        
                        Biological Science Technician (Plants)
                        Phone: (509) 335-4955
                        
                        
                        Fax: (509) 335-7692(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)
                            **Publications**
                                                (Clicking on the reprint icon
                                                    Reprint Icon
                                                    will take you to the publication reprint.)Pollen as a means of international transfer of germplasm

- (Peer Reviewed Journal)Mallikarjuna, N., Mcgrew, S.L., Rynearson, S., Rajest, P.N., Coyne, C.J., Muehlbauer, F.J. 2007. Pollen as a means of international transfer of germplasm. Journal of Semi-Arid Tropical Agricultural Research (eJournal of J.SAT Agric. Res. 3(1):www.icrisat.org/Journal/chickpea_pigeonpea3.htm.


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-875]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Globyz Pharma, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 13, 2021. Such persons may also file a written request for a hearing on the application on or before September 13, 2021.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 7, 2021, Globyz Pharma, LLC., 2101 Market Street, Suite 5, Upper Chichester, Pennsylvania 19061-4001, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleLisdexamfetamine
1205
I
 The company plans to import finished dosage unit products of Lisdexamfetamine for the one time need of analytical testing. No other activity for this drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Brian S. Besser, Acting Assistant Administrator.


[FR Doc. 2021-17181 Filed 8-11-21; 8:45 am] BILLING CODE P
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-16-00309-CV

Waterworks Corral Creek, LLC; and Saltwater Disposal Systems, LLC, Appellants

v.

Aquatech Saltwater Disposal LLC d/b/a AquaTech Water & Disposal, LLC; and

Eric Schmitz, Appellees

FROM THE DISTRICT COURT OF TRAVIS COUNTY, 200TH JUDICIAL DISTRICT

NO. D-1-GN-15-001943, HONORABLE KARIN CRUMP, JUDGE PRESIDING

M E M O R A N D U M O P I N I O N

PER CURIAM

Appellants have filed a motion to stay proceedings in the district court while their

interlocutory appeal is pending in this Court. In their response to the motion, appellees informed the

Court that the parties are scheduled to attend a mediation ordered by the district court and that the

mediation is scheduled for July 14, 2016. We abate this appeal to allow the parties to conduct the

scheduled mediation. See Tex. R. App. P. 29.3 (appellate court may make any temporary orders

necessary to preserve parties’ rights). The parties shall submit either a joint status report concerning

the status of settlement negotiations or a motion to reinstate on or before August 1, 2016. The appeal

will remain abated until further order of this Court.
Before Chief Justice Rose, Justices Pemberton and Bourland

Abated

Filed: June 30, 2016

2
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Agroecosystem Management Research: Lincoln, NE
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Lincoln, Nebraska Agroecosystem Management Research People & Locations







Alexis T Overman
                        Agroecosystem Management Research

                        




                        
                        Biological Science Technician
                        Phone: (402) 910-5863
                        
                        
                        Fax: (402) 472-4020(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
#### Hoosac Valley Farmers’ Exchange, Respondent, v George Lewis, Appellant, et al., Defendants.

—Weiss, J.

Appeal from that part of an order of the Supreme Court at Special Term (Prior, Jr., J.), entered January 22, 1985 in Rensselaer County, which denied defendants’ motion to vacate a default judgment against George Lewis, individually.

The underlying action on an account stated for agricultural goods sold and delivered was commenced on November 17, 1983 by personal service of a summons and complaint on George Lewis and Delwin Lewis and Sons, Inc., a Vermont corporation (hereinafter corporation) of which Lewis was president. On December 20, 1983, a default judgment was entered in plaintiffs favor upon defendants’ failure to timely answer. In the interim, the corporation filed a petition in bankruptcy which plaintiff acknowledges vitiated the default judgment as against the corporation. Although Lewis concedes that he received the initial process, defendants’ motion to vacate the default judgment was not made until October 9, 1984. While Special Term granted the motion as to the corporation, the motion was denied as to Lewis for failure to present a viable excuse as to the default. Lewis has appealed.

We affirm. It is well established that a party seeking vacatur of a default judgment must, pursuant to CPLR 5015 (a) (1), demonstrate both a reasonable excuse for the default and a meritorious defense *(see, Elgart v Raleigh Hotel Corp.,*115 AD2d 165). An examination of the papers before Special Term confirms that Lewis failed to offer any reason vindicating his tardiness. Nor are we persuaded by the suggestion in his brief that the corporation’s bankruptcy petition influenced him not to serve an answer. It was incumbent upon Lewis to present a viable excuse for his own inaction. Having failed to do so, we cannot say that Special Term abused its discretion in refusing to vacate the default as against Lewis *(see, Passalacqua v Banat,*103 AD2d 769, *appeal dismissed*63 NY2d 770; *Tucker v Rogers,*95 AD2d 960, 961; *Kirkman/3hree, Inc. v Priority AMC/Jeep,*94 AD2d 870, 870-871).

Order affirmed, with costs. Mahoney, P. J., Kane, Weiss, Mikoll and Levine, JJ., concur.